ClinicalTrials.Veeva

Menu
I

Innovative Health Research | Las Vegas, NV

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

IPP-201101
Ustekinumab
AC2993
Ianalumab
Cenerimod
Tabalumab
PF-06700841
Abatacept
Afimetoran
Baricitinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 17 total trials

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythema...

Enrolling
Systemic Lupus Erythematosus
Other: Placebo
Drug: Afimetoran

The trial will evaluate efficacy, safety and tolerability of two regimens of ianalumab compared to placebo, given as monthly or quarterly subcutaneou...

Enrolling
Systemic Lupus Erythematosus
Drug: Placebo
Drug: Ianalumab

Trial sponsors

Bristol-Myers Squibb (BMS) logo
I
Lilly logo
Sandoz logo
AbbVie logo
AstraZeneca logo
Idorsia Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
Novartis logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems